Commentary

Perspective: Jojoba


 

Dr. Baumann writes the column “Cosmeceutical Critique,” which regularly appears in Skin and Allergy News, an Elsevier publication. Dr. Baumann is in private practice in Miami Beach. To respond to this column, or to suggest topics for future columns, e-mail Dr. Baumann at sknews@elsevier.com.

Pages

Recommended Reading

Toxic Erythema of Chemotherapy By Any Other Name
MDedge Internal Medicine
Bosentan Reduced Occurrence of Digital Ulcers in Systemic Sclerosis
MDedge Internal Medicine
'Sunless' Tanning Intervention Cuts Women's UV Exposure
MDedge Internal Medicine
Epidermolysis Bullosa Wounds Heal Rapidly Following Fibroblast Injections
MDedge Internal Medicine
Sunscreen Ingredients Retinyl Palmitate, Oxybenzone Get Second Look
MDedge Internal Medicine
Dermoscopy Underutilized in United States
MDedge Internal Medicine
TNF Antagonists in Rheumatic Patients Linked With Increased Hospitalization for Varicella Zoster
MDedge Internal Medicine
Octagam Withdrawn From U.S. Market
MDedge Internal Medicine
Repeat Weak Positive Patch Tests for Allergy
MDedge Internal Medicine
Perspective: Incoherence
MDedge Internal Medicine